Development of a new subclavian arterial infusion chemotherapy method for locally or recurrent advanced breast cancer using an implanted catheter-port system after redistribution of arterial tumor supply.
PMID:
Acute myeloid leukaemia.
Short NJ, Rytting ME, Cortes JE.
Lancet. 2018 Aug 18;392(10147):593-606. doi: 10.1016/S0140-6736(18)31041-9. Epub 2018 Aug 2.
PMID:30078459
A review of treatment options employed in relapsed/refractory AML.
Mohamed Jiffry MZ, Kloss R, Ahmed-Khan M, Carmona-Pires F, Okam N, Weeraddana P, Dharmaratna D, Dandwani M, Moin K.
Synthetic lethality as an engine for cancer drug target discovery.
Huang A, Garraway LA, Ashworth A, Weber B.
Nat Rev Drug Discov. 2020 Jan;19(1):23-38. doi: 10.1038/s41573-019-0046-z. Epub 2019 Nov 11.
PMID:31712683
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy.
Coccolini F, Fugazzola P, Ansaloni L, Sartelli M, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Catena F.
Acta Biomed. 2018 Dec 17;89(8-S):104-109. doi: 10.23750/abm.v89i8-S.7904.
PMID:30561427
Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary report.
Kuske RR, Perez CA, Grigsby PW, Lovett RD, Jacobs AJ, Galakatos AE, Camel HM, Kao MS.
Am J Clin Oncol. 1989 Dec;12(6):467-73. doi: 10.1097/00000421-198912000-00002.
PMID:2686392
Chemotherapy in advanced and recurrent cervical cancer. A review.